What one share of International Stem Cell holds
International Stem Cell Corporation (sometimes referred to herein as “ISCO”, the “Company”, “we”, “us”, or “our”) is a clinical stage biotechnology company focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities and two revenue-generating businesses offering potential for increased future revenue.
International Stem Cell’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.19 |
|---|---|
| Profit | −$0.07 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.04 |
| Cash and investments | $0.14 |
| Book value | −$0.53 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $3.46 | −$31.50 | $0.66 | −$15.99 | — | $10.81 |
| 2011 | $8.79 | −$18.00 | $1.10 | −$14.61 | — | $6.79 |
| 2012 | $7.97 | −$19.79 | $0.34 | −$12.02 | — | −$3.02 |
| 2013 | $7.49 | −$13.50 | $0.20 | −$7.07 | — | −$4.19 |
| 2014 | $5.81 | −$10.34 | $0.24 | −$5.56 | — | $0.20 |
| 2016 | $2.25 | −$0.34 | $0.07 | −$1.39 | — | $0.87 |
| 2017 | $1.79 | −$1.46 | $0.03 | −$0.54 | — | $0.34 |
| 2018 | $1.74 | −$0.33 | $0.03 | −$0.20 | — | $0.37 |
| 2019 | $1.26 | −$0.57 | $0.02 | −$0.21 | — | −$0.38 |
| 2020 | $0.95 | −$0.36 | $0.00 | −$0.05 | — | −$0.57 |
| 2021 | $0.92 | −$0.11 | $0.00 | −$0.17 | — | −$0.57 |
| 2022 | $1.02 | −$0.04 | $0.00 | $0.04 | — | −$0.56 |
| 2023 | $0.97 | −$0.02 | $0.01 | $0.11 | — | −$0.52 |
| 2024 | $1.14 | −$0.03 | $0.02 | −$0.02 | — | −$0.49 |
| 2025 | $1.14 | −$0.05 | $0.01 | −$0.00 | — | −$0.51 |
Common questions about International Stem Cell
How much does one share of International Stem Cell earn?
Over the last 12 months, International Stem Cell lost $0.07 for each share on $1.19 of sales.
Does International Stem Cell pay a dividend?
International Stem Cell didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is International Stem Cell’s book value per share?
International Stem Cell’s book value is negative (−$0.53 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of International Stem Cell have?
Each share of International Stem Cell has $0.14 of cash and investments, as of June 30, 2026.
What is International Stem Cell’s free cash flow per share?
$0.04 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has International Stem Cell bought back shares?
International Stem Cell’s share count rose about 1665% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.